ACI Earnings

ACI reported its earnings on 2026-01-07, showcasing a revenue of 19.12B against an estimate of 19.16B, resulting in a -0.19% surprise. The EPS was 0.69, surpassing the expected 0.63 by 9.52% . The stock experienced a -5.96% price change on the earnings day and a 0.64% change over the next five days, reflecting market reactions to the results.

Following ACI's earnings announcement on 2026-01-07, the stock price moved by -5.96% on the day of the release. Over the subsequent five days, it saw a 0.64% change. Historically, ACI's stock price tends to shift by an average of +1.11% in the 10 days leading up to earnings and -0.28% in the 10 days following, providing insight into potential market.

For 2026/Q4, analysts estimate ACI’s annual revenue to reach 20.46B, while the EPS is projected at 0.45. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between ACI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2026 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ACI's stock price typically moves by +1.11% in the 10 days before its earnings and -0.28% in the 10 days after. For the upcoming 2026/Q4 earnings, analysts expect an EPS of 0.45 and revenue of 20.46B.

The earnings call summary and Q&A session reveal strong growth in pharmacy and digital sales, optimistic guidance, and effective cost savings initiatives. Despite concerns about inflation and promotional environment, the company's strategic investments in technology and customer engagement are promising. Share repurchase plans and improved EPS guidance also contribute positively. Overall, these factors suggest a positive stock price movement over the next two weeks.